Wolfgang Richter

Title: Wolfgang Richter: Innovator in Antibody Technology

Introduction

Wolfgang Richter is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 7 patents to his name, Richter's work focuses on innovative solutions for activating T cells, which are crucial in the treatment of various diseases.

Latest Patents

One of Wolfgang Richter's latest patents involves antibodies that bind to CD3 and CD19. This invention relates to antibodies designed for activating T cells, which play a vital role in the immune response. The patent also covers polynucleotides encoding these antibodies, as well as vectors and host cells that incorporate such polynucleotides. Furthermore, the invention outlines methods for producing these antibodies and their applications in disease treatment.

Career Highlights

Throughout his career, Wolfgang Richter has worked with notable companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in antibody technology.

Collaborations

Wolfgang Richter has collaborated with esteemed colleagues such as Anne Freimoser-Grundschober and Ralf Hosse. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies in the field.

Conclusion

Wolfgang Richter's contributions to antibody technology and his innovative patents underscore his role as a leading inventor in the biotechnology sector. His work continues to impact the treatment of diseases, showcasing the importance of innovation in healthcare.